CRVS vs CYRX: stock comparison and AI forecast
Corvus Pharmaceuticals, Inc. (CRVS) and Cryoport, Inc. (CYRX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CRVS Corvus Pharmaceuticals, Inc.
- Price
- $9.73 -33.3% · 6M
- Market Cap
- $818M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
CYRX Cryoport, Inc.
- Price
- $16.05 +25.8% · 6M
- Market Cap
- $813M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- CRVS and CYRX have similar market capitalizations ($818M and $813M).
- Over the last six months CYRX returned +25.8% and CRVS -33.3%.
- CYRX carries 0.55 times debt per unit of equity, against 0.07 times for CRVS.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CRVS | CYRX |
|---|---|---|
| Market Cap | $818M | $813M |
| P/B Ratio | 3.93x | 1.68x |
| EPS | $-0.63 | $-0.72 |
| Book Value/Share | $2.48 | $9.55 |
| Revenue/Share | – | $3.80 |
| FCF/Share | $-0.57 | $-0.37 |
Profitability & Margins
| Metric | CRVS | CYRX |
|---|---|---|
| ROE | -30.9% | -7.8% |
| ROA | -28.7% | -5.0% |
| ROIC | -32.5% | -6.9% |
| Gross Margin | – | 46.9% |
| Operating Margin | – | -18.8% |
| Net Margin | – | -19.5% |
| EBT Margin | – | -17.1% |
| Tax Rate | 0.0% | -5.9% |
Financial Health
| Metric | CRVS | CYRX |
|---|---|---|
| Current Ratio | 13.38x | 2.04x |
| Quick Ratio | – | 1.94x |
| D/E Ratio | 0.07x | 0.55x |
| Financial Leverage | 1.07x | 1.55x |
| Interest Coverage | – | -11.3x |
| Working Capital | $191M | $233M |
Cash Flow
| Metric | CRVS | CYRX |
|---|---|---|
| Operating Cash Flow | -$47M | $11M |
| Free Cash Flow | -$48M | -$19M |
| Capital Spending | -$760K | -$30M |
| FCF/Sales | – | -9.8% |
| CapEx/Sales | – | 15.5% |
Operational Efficiency
| Metric | CRVS | CYRX |
|---|---|---|
| Asset Turnover | – | 0.26x |
| Receivables Turnover | – | 5.3x |
| Inventory Turnover | – | 4.5x |
| Fixed Assets Turnover | – | 2.0x |
| Days Sales Outstanding | – | 68 days |
| Days Inventory | – | 80 days |
Income Statement
| Metric | CRVS | CYRX |
|---|---|---|
| Total Revenue | – | $192M |
| Operating Income | -$68M | -$36M |
| Net Income | -$64M | -$38M |
| R&D Expense | $55M | $18M |
| SG&A Expense | – | $109M |
| Cost of Goods Sold | – | $102M |
Dividend & Shareholder Information
| Metric | CRVS | CYRX |
|---|---|---|
| Shares Outstanding | 84M | 51M |
| Net Income Growth | – | -155.7% |
| EPS Growth | – | -170.6% |
CRVS vs CYRX: stock comparison and AI forecast
Which is bigger, CRVS or CYRX?
CRVS and CYRX have similar market capitalizations ($818M and $813M).
Which stock performed better over the last six months, CRVS or CYRX?
Over the last six months CYRX returned +25.8% and CRVS -33.3%.
Which one does Intratio's AI model rank higher, CRVS or CYRX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.